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Paul E MarikAbstract
The birth of the intermittent injectate-based conventional pulmonary artery catheter (fondly nicknamed PAC) was
proudly announced in the New England Journal of Medicine in 1970 by his parents HJ Swan and William Ganz. PAC
grew rapidly, reaching manhood in 1986 where, in the US, he was shown to influence the management of over
40% of all ICU patients. His reputation, however, was tarnished in 1996 when Connors and colleagues suggested
that he harmed patients. This was followed by randomized controlled trials demonstrating he was of little use.
Furthermore, reports surfaced suggesting that he was unreliable and inaccurate. It also became clear that he was
poorly understood and misinterpreted. Pretty soon after that, a posse of rivals (bedside echocardiography, pulse
contour technology) moved into the neighborhood and claimed they could assess cardiac output more easily, less
invasively and no less reliably. To make matter worse, dynamic assessment of fluid responsiveness (pulse pressure
variation, stroke volume variation and leg raising) made a mockery of his ‘wedge’ pressure. While a handful of
die-hard followers continued to promote his mission, the last few years of his existence were spent as a castaway
until his death in 2013. His cousin (the continuous cardiac output PAC) continues to eke a living mostly in cardiac
surgery patients who need central access anyway. This paper reviews the rise and fall of the conventional PAC.
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Pulmonary artery (PA) catheterization was first per-
formed by Lewis Dexter in 1945 [1]. After observing a
spinnaker on a sailboat off Santa Monica beach, the idea
of a flow-directed PA catheter (PAC) was developed by
Swan and Ganz in 1970, allowing bedside placement [2].
The PAC was subsequently modified with a thermistor
to allow measurement of cardiac output (CO) [3].
Shortly after the publication by Swan et al. in 1970, the
balloon tipped PA catheter became commercially avail-
able and it began to be used in a variety of clinical
settings. The use of the PAC moved from the cardiac
catheterization laboratory to the ICU and operating
room and its use changed from being used as a diagnos-
tic to a therapeutic tool. Clinicians began to use the
hemodynamic data derived from the PAC to select,
modify and monitor medical treatments. After the intro-
duction of the PAC, enthusiasm for the device increased
and its use increased exponentially. Indeed, the PAC
became the cornerstone of critical care and a hallmark
of the ICU. In the 1980s 20% to 40% of seriously illCorrespondence: marikpe@evms.edu
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medium, provided the original work is properlypatients who were hospitalized were reported to undergo
pulmonary artery catheterization [4]. This phenomenon
occurred despite that fact that the safety, accuracy, and
benefit of the device had never been established.
Eugene Robin was the first clinician to challenge the
widespread adoption of the PAC. He wrote two edito-
rials in the mid 1980s in which he called for a morator-
ium on the use of the PAC until randomized controlled
trials (RCTs) were performed which demonstrated the
safety and improved outcomes associated with the use of
the PAC [5,6]. A decade later the landmark study
by Connors and coworkers was published [7]. Using
propensity matching, this study demonstrated a 24%
increased risk of death in ICU patients who received a
PAC within 24 hours of admission to an ICU. The first
large randomized, controlled, prospective, evaluation of
the PAC was published by Sandham and colleagues in
2003 [8]. These authors randomized 1,994 high risk
patients aged 60 years or older who were scheduled for
major surgery to goal directed therapy guided by a PAC
compared to standard care without a PAC. Hospital and
six month mortality and length of stay were similar
between the two groups. Except for pulmonary embol-
ism, which was higher in the PAC group, morbidity wasaccess article distributed under the terms of the Creative Commons Attribution
y/2.0), which permits unrestricted use, distribution, and reproduction in any
cited.
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European studies conducted in critically ill ICU patients
and the ESCAPE trial in patients with heart failure
which failed to demonstrate any benefit from the PAC
[9-11]. A meta-analysis conducted by the Cochrane
group demonstrated no benefit from the use of the PAC
in high risk surgery patients (eight studies) and general
ICU patients (four studies) [12]. In the US, the use of
the PAC peaked between 1993 and 1996 with a rate
of 5.6 per 1,000 hospital admissions, declining to a rate
of 1.99 per 1,000 hospital admissions in 2004 [4]. The
decline in the use of the PAC appears to have followed
the publication of the Connors study in 1996 [7].
Current utilization of the PAC in ICU’s in the US is
unknown, with most PACs being placed in patients
undergoing cardiothoracic surgery. Despite dramatic
reductions in the routine use of the PAC in cardiac
surgery to less than 20% of cases in Europe and less than
10% in Japan, some centers in North America and
Australia still routinely use the device [13,14].
The PAC provides hemodynamic data that cannot be
obtained from clinical examination. It was therefore
widely believed that the data obtained from the PAC
would allow a better understanding of the patients
hemodynamic profile and that this would lead to thera-
peutic interventions which would improve patient out-
comes [15]. This premise was based on the assumption
that the data obtained from the PAC were accurate, that
clinicians were able to interpret the data and that the
data themselves were useful in managing critically ill
patients. However the evidence suggests that these three
assumptions are incorrect. Furthermore, it is likely that
information obtained from the PAC triggers inappropri-
ate therapy that may be harmful.
The data provided by the PAC may not be accurate
The CO and pulmonary capillary wedge pressure
(PCWP) are the hemodynamic parameters obtained from
the PAC which are most frequently used to make thera-
peutic decisions. Furthermore, these variables are used in
the calculation of many of the other hemodynamic
parameters. However, the inaccuracies of both of these
variables essentially preclude them from being used for
this purpose.
Adolph Fick described the first method of CO estima-
tion in 1870 [16]. The direct Fick method was the refer-
ence standard by which all other methods of
determining CO were evaluated until the introduction of
the PAC. Currently the PAC is considered the ‘Gold
Standard’ against which other devices are compared.
Despite the ubiquitous use of the PAC, remarkably few
studies have investigated the accuracy of the CO mea-
surements as determined by thermodilution. In 1982
Stetz and colleagues analyzed the reliability of the PACand reported a precision of 15%; that is, there must be a
minimal difference of 15% between determinations of
CO (three measurements per determination) to suggest
clinical significance [17]. This study became the refer-
ence standard for the PAC, with a precision of 15%
being used in studies evaluating fluid responsiveness.
However, more recent studies have been unable to
reproduce the findings of Stetz and colleagues. Dhingra
and coauthors compared the thermodilution CO with
that measured by the Fick technique over a wide range
of cardiac outputs [18]. The bias was −0.17 L/min with
the upper and lower limits of agreement being 2.96
L/min and −3.30 L/min, respectively. The percentage
error was 62%. When compared to the direct Fick
method the PAC has a percentage error of 56 to 83%
[18-20]. The percentage error (2 SD/μ) is derived by the
Bland-Altman method with a percentage error of up to
30% being considered clinically acceptable [21]. Philips
et al. compared thermodilution CO with surgically
implanted ultrasonic flow probes in an ovine model [22].
The percentage bias and precision was −17% and 47%
respectively; the PAC under-measured dobutamine-
induced CO changes by 20% (relative 66%) compared
with the flow probe. This study found that the PAC was
an inaccurate measure of CO and was unreliable for
detection of CO changes less than 30%. Critchely et al.,
using a similar methodology in pigs, reported a precision
of 26% [23]. These studies suggest that the true CO has
to change by at least 25% to be detected by the PAC.
Furthermore, the required change may be as high as
100% depending on the monitor being used [24].
It is likely that multiple factors interact to affect the
accuracy of the thermodilution CO calculation [25].
Occult warming of cold indicator before injection can
produce indicator loses leading to overestimates of CO.
Significant losses of thermal indicator arise from the
dissipation of cold indicator through the intravascular
portions of the catheter which have been pre-warmed by
the surrounding blood. Spontaneous or mechanical ven-
tilation affects the actual CO; the SV can vary by as
much as 50% at various phases of the respiratory cycle
[26,27]. The averaging of multiple measurements at
different phases of the respiratory cycle has therefore
been proposed. It is unclear how many measurements
are needed for sufficient accuracy and reproducibility,
but it seems that three, although clinically mostly per-
formed, is insufficient. PA thermodilution CO measure-
ments are unreliable in the presence of tricuspid
regurgitation. In general CO is underestimated in
patients with tricuspid regurgitation [28-30]. This find-
ing is important as the incidence of tricuspid regurgita-
tion is about 15% in the general population increasing to
greater than 70% in elderly patients [31-33]. It should be
noted that the reproducibility of CO measurements by
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ter than that of the PAC with a precision of about 7%
[34,35]. The better precision of transpulmonary thermo-
dilution compared to the PAC is probably related to the
longer transit time of the thermal bolus which is not
influenced by respiration and arrhythmias.
In addition to providing CO data that are inaccurate, a
number of factors may lead to erroneous PCWP mea-
surements. The accurate and consistent placement of
pressure transducers for invasive monitoring is critically
important. Errors in zeroing and obtaining baseline mea-
surements are exceedingly common and may result in
changes in the PA and PCWP pressure of up to 6 mmHg
[36,37]. Furthermore the patient’s position is frequently
not standardized, leading to further errors in measure-
ment [38]. Figg and Nemergut demonstrated significant
variation in transducer placement for central venous
pressure (CVP) measurement amongst perioperative
health care providers [39]. Damped tracings and catheter
‘fling’ may not be recognized, leading to erroneous mea-
surements [38]. These errors are compounded in
patients on mechanical ventilators where the use of posi-
tive pressure ventilation, spontaneous breaths and the
use of positive end expiratory pressure (PEEP) make
analysis of the PCWP challenging and unreliable
[36,40,41].
Risks from the PAC itself
The complications that may arise directly from the use
of the PAC include pulmonary artery rupture, pulmon-
ary artery thrombosis, intra-cardiac knotting of the cath-
eter, pulmonary hemorrhage, right atrial thrombosis,
catheter related bloodstream infection, internal jugular/
subclavian vein stenosis or thrombosis, atrial and ven-
tricular arrhythmia, electromechanical dissociation and
right-sided endocarditis. These risks may not be trivial.
A study of 70 critically ill patients demonstrated that 4%
died from complications related to the PAC and that
between 20 and 30% had major complications related to
the PAC [42]. Fatal air embolism related to the PAC
introducer has also been reported [43-45].
Harm due to knowledge deficit
Studies suggest that clinicians are unable to correctly
interpret the data obtained from the PAC even if one
assumes that these measurements are accurate. A 1990
study by Iberti et al., in which a 31-item examination on
the PAC was completed by 496 North American ‘intensi-
vists’ found that only 67% of the answers were correct
[46]. The instrument yielded similar results in Europe
[47]. A 1996 survey of more than 1,000 critical care phy-
sicians found that, although 83% of questions were
answered correctly, a third of the respondents could not
correctly identify the PCWP on a clear tracing and couldnot identify the major components of oxygen transport
[48]. Large interobserver variability has been reported in
the interpretation of PAC pressure tracings with little
agreement between ‘experts’ [49-51]. A survey of prac-
ticing cardiac anesthesiologists concluded that ‘a large
proportion of anesthesiologists who use the PAC
disagree about PCWP estimation, and even those who
agree may lack the confidence necessary to use it effect-
ively’ [52]. What is most disturbing is that when board
certified intensivists are provided with the same PAC
data there is enormous variability in the intervention
consequent to ‘interpretation’ of the data [51]. Remark-
ably, while clinicians acknowledge that ‘other practi-
tioners’ have a poor understanding on the PAC and the
interpretation of the ‘hemodynamic profile’ derived from
the PAC, they believe that they have a good understand-
ing of the PAC and that in their ‘hands’ the PAC is a
useful and beneficial device [51-53]. Similar problems
concerning a ‘knowledge deficit’ have been identified
among critical care nurses [54]. Johnson and colleagues
using the same questionnaire as Iberti et al. in a cohort
of ICU nurses demonstrated only 42% of questions were
answered correctly [55]. In this study, 51% of respon-
dents were unable to correctly identify the pressure
change as the catheter was advanced from the right ven-
tricle to the PA. It is clear that this ‘knowledge deficit’ is
a major factor contributing to the lack of benefit
(? harm) of the PAC.
The data obtained from the PAC may not be useful in
managing critically ill patients
A major factor explaining the lack of benefit of the PAC
may be that the data obtained are not useful in man-
aging critically ill patients. A commonly cited benefit of
the PAC is that it provides filling pressures which can be
used to identify fluid responsiveness and guide fluid
administration [15]. However, these filing pressures have
been found to be neither uniformly accurate nor effect-
ive for fluid guidance. The PCWP suffers from the same
limitation as the central venous pressure (CVP) [56,57].
Multiple studies have shown a poor relationship between
the PCWP and circulating blood volume, SV and left
ventricular end-diastolic volume [58-63]. Furthermore,
the PCWP is unable to predict fluid responsiveness
[64-66]. These data indicate that the PCWP should not
be used to make decisions regarding fluid management.
Furthermore, due to the inherent inaccuracy of the CO
measurement the change in the SV following a fluid
bolus cannot be used to determine fluid responsiveness
nor construct a Frank-Starling curve. An increase in SV
of 10 to 15% is used to define fluid responsiveness [66].
This threshold is significantly below the ability of the
PAC to detect a change in CO [22]. In addition to its
inability to determine fluid responsiveness the CO itself
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Attempts at increasing CO and/or achieving supra-
normal levels of oxygen delivery in medical patients have
universally failed to positively impact patient outcome
[9,12,67]. Indeed, the study by Hayes and colleagues
demonstrated that such an approach is harmful [68].
‘Paradoxically’, Morelli et al. demonstrated that in the
setting of septic shock, the use of a beta-blocker which
reduced CO and oxygen delivery improved patient
survival [69].
The PAC results in ‘overtreatment’
Survey studies in postoperative and ICU patients have
demonstrated that the PAC provided ‘new information’
or seemed to change therapy in 30 to 62% of cases
[70-72]. However, the clinical significance of these
changes is uncertain and in the absence of demonstrated
benefit it is likely that many of these interventions were
not beneficial. Fellahi et al. demonstrated a significant
independent increase in cardiac morbidity and in-
hospital mortality in cardiac surgical patients who
received dobutamine to improve CO based on PAC
values [73]. Sandison et al. compared the outcome of
patients undergoing non-elective abdominal aortic
aneurysm repair in two different centers [74]. In the one
center, PACs were inserted in 96% of cases versus 18%
in the other. The patients in the center with higher PAC
usage received more crystalloid, colloid and inotropes.
Their incidence of renal failure was noted to be higher
as were their lengths of stay in both ICU and hospital.
These data suggest that placement of a PAC may result
in excessive and inappropriate therapeutic interventions
that have the potential to harm patients.
Potential benefits of the PAC
The benefits of the PAC are somewhat difficult to define.
In some patients the diagnosis between non-cardiogenic
and cardiogenic pulmonary edema is difficult to make.
In such circumstance the PCWP has been used to make
this distinction. However, with advancements in echo-
cardiography, catheterization of the pulmonary artery
for this purpose is seldom required. It would appear that
the role of the PAC is limited to diagnosing patients with
pulmonary hypertension and managing these patients in
the perioperative period (see below), as well as the diag-
nosis of intracardiac shunts (echocardiography may be
better) and amniotic fluid embolism [75].
Indications for the use of the PAC
Doppler echocardiography is frequently used to calculate
the pulmonary artery systolic pressure (sPAP). However,
the sPAP as determined by Doppler echocardiography is
an inaccurate estimate of sPAP, [76,77] and this technol-
ogy is not considered a reliable method for the diagnosisand management of pulmonary arterial hypertension
(PAH) [78]. Pulmonary artery catheterization is therefore
required to confirm the diagnosis of PAH, classify PAH,
assess its severity and to test the vasoreactivity of the
pulmonary circulation [79,80]. Pulmonary artery cathe-
terization has been recommended in patients with sig-
nificant PAH (sPAP > 50 mmHg and/or RV enlargement)
undergoing a major surgical intervention [81]. While
this recommendation is not supported by high quality
evidence, it would appear to be logical as the PA pres-
sure is the only reliable hemodynamic parameter derived
from the PAC and its use may allow for the rational ti-
tration of vasoactive agents.
Over 30 randomized controlled trials have studied
perioperative hemodynamic optimization in a variety
of settings, using various goals and techniques of
hemodynamic optimization [82-84]. This approach has
been demonstrated to reduce the risk of complications
and mortality in elective non-cardiac surgery patients
[82-84]. The initial preemptive hemodynamic studies
used the PAC and targeted ‘supranormal’ goals while
more recent studies have ‘optimized’ CO using esopha-
geal Doppler or dynamic indices of fluid responsiveness.
Meta-analyses of these studies have demonstrated that
both approaches reduce surgical mortality and morbidity
[82-84]. In addition, these meta-analyses have demon-
strated that the PAC has been largely replaced by less
invasive hemodynamic monitoring techniques.Conclusions
There is no evidence that the use of the PAC has
improved patient outcomes. There are, however, convin-
cing data that the hemodynamic parameters obtained
from the PAC are inaccurate, are incorrectly interpreted
and that these data frequently lead to excessive and
inappropriate therapeutic interventions that maybe
harmful. In addition, the data suggest that the hemo-
dynamic parameters obtained from the PAC have little
utility in managing critically ill patients in the ICU and
operating room. These data therefore suggest that the
PAC has a limited role in the ICU and operating room
and challenge those experts who believe that the ‘pul-
monary artery catheter is still a valuable tool for
hemodynamic monitoring’ [85]. The PAC, however, has a
role in the diagnosis and operative management of
patients with pulmonary hypertension and acute right
ventricular failure.Abbreviations
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pressure; PAH: Pulmonary artery hypertension; RV: Right ventricle.
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